FGF21 and metabolic dysfunction-associated steatohepatitis: Evidence from studies in adults show that elevated FGF-21 levels reduce hepatic lipogenesis and improve insulin sensitivity (25, 26) and are negatively correlated with the probability of NAFLD and NASH (14).